Parkinson's cell therapy biotech Aspen and I&I startup Bambusa file for IPOs

Summary

Aspen Neuroscience, a Gilead-backed cell therapy biotech focused on Parkinson's disease, and Bambusa Therapeutics, an immunology startup founded by BioNTech veterans, have filed for IPOs as the biotech industry experiences increased public market activity.